How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,188 results for

"Anxiety"

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

301. COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response

reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 111 1 Communicating with patients and minimising Communicating with patients and minimising risk risk 1.1 Communicate with patients, their families and carers, and support their mental wellbeing to help alleviate any anxiety and fear they may have about COVID-19. Signpost to charities (such as Crohn's & Colitis UK, the British Liver Trust, the Crohn's in Childhood Research Association

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

302. COVID 19 rapid guideline: renal transplantation

Communication and minimising risk Communication and minimising risk 6.1 Communicate with patients, potential living donors, their families and carers, and support their mental wellbeing to help alleviate any anxiety they may have about COVID-19. Signpost to sources of information, support groups (including NHS Volunteer Responders) and government guidance. For example: • UK government guidance on the mental health and wellbeing aspects of COVID-19 • Kidney Care UK COVID-19 guidance for patients with kidney

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

303. COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD)

guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD) (NG168) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 131 1 Communicating with patients and minimising Communicating with patients and minimising risk risk 1.1 Communicate with patients, their families and carers, and support their mental health and wellbeing to help alleviate any anxiety and fear they may have about (...) is as stable as possible. This includes those with COVID-19, or who are suspected of having it. Keep their self-management plan up to date, and remind them that online video resources on correct inhaler technique are available. 2.2 At every interaction with a patient, be alert for new or increased issues with mental health and wellbeing, particularly anxiety and depression. 2.3 Find out if patients have advance care plans or advance decisions around ceilings of care, including 'do not attempt

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

304. COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response

) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 131 1 Communicating with patients and minimising Communicating with patients and minimising risk risk 1.1 Communicate with patients, their families and carers, and support their mental health and wellbeing to help alleviate any anxiety and fear they may have about COVID-19. Signpost to sources of online information (such as the British Association

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

305. COVID-19 rapid guideline: cystic fibrosis

the recommendations as the knowledge base and expert experience develops. COVID-19 rapid guideline: cystic fibrosis (NG170) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 111 1 Communicating with patients and minimising Communicating with patients and minimising risk risk 1.1 Communicate with patients, their families and carers, and support their mental health and wellbeing to help alleviate any anxiety and fear they may

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

306. COVID-19 rapid guideline: delivery of systemic anticancer treatments

and have been verified as far as possible. We will review and update the recommendations as the knowledge base and expert experience develops. © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 131 1 Communicating with patients Communicating with patients 1.1 Communicate with patients and support their mental wellbeing, signposting to charities and support groups where available, to help alleviate any anxiety

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

307. COVID-19 rapid guideline: dialysis service delivery

reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 171 1 Communicating with patients Communicating with patients 1.1 Communicate with patients and support their mental wellbeing to help alleviate any anxiety and fear they may have about COVID-19. Point them to resources such as Kidney Care UK. 1.2 T ell patients to alert their dialysis unit if they are unwell. Ask them and their carers to report COVID-19 relevant symptoms before leaving

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

308. COVID-19 rapid guideline: delivery of radiotherapy

, signposting to charities and support groups (including NHS volunteers) where available, to help alleviate any anxiety and fear they may have about COVID-19. 1.2 Minimise face-to-face contact by: • offering telephone or video consultations whenever possible • cutting non-essential face-to-face follow up, and minimising the number of on-treatment reviews • using alternative ways of delivering medicines, such as postal services, NHS volunteers, or drive-through pick-up points • using local services for blood

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

309. Colorectal cancer

treatments for colorectal cancer information about possible short-term, long-term, permanent and late side effects which can affect quality of life, including: pain altered bowel, urinary or sexual function nerve damage and neuropathy mental and emotional changes, including anxiety, depression, chemotherapy-related cognitive impairment, and changes to self-perception and social identity. Colorectal cancer (NG151) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

310. COVID-19 rapid guideline: severe asthma

Foundation) to help alleviate any anxiety and fear they may have about COVID-19. 1.2 Be aware that severe asthma is defined by the European Respiratory Society and American Thoracic Society as asthma that requires treatment with high- dose inhaled corticosteroids (see inhaled corticosteroid doses for NICE's asthma guideline) plus a second controller (and/or systemic corticosteroids) to prevent it from becoming 'uncontrolled' , or which remains 'uncontrolled' despite this therapy. 1.3 Some patients

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

311. COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders

and support groups (such as ARMA, which has a list of relevant organisations, and NHS Volunteer Responders) where available, to help alleviate any anxiety and fear they may have about COVID-19. 1.2 Minimise face-to-face contact by: • cutting non-essential face-to-face consultations • offering telephone or video consultations • contacting patients via text message or email • making use of departmental pages on local NHS trust websites • using rheumatology department advice services, including out-of-hours

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

312. COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community

to contact. 1.2 Support patients' mental wellbeing, signposting to charities and support groups (including NHS volunteers) where available, to help alleviate any anxiety and fear they may have about COVID-19. 1.3 Minimise face-to-face contact by: • offering telephone or video consultations (see the BMJ guidance on COVID-19: a remote assessment in primary care for a useful guide, including a visual summary for remote consultations) • cutting non-essential face-to-face follow-up • using electronic rather (...) of hospital admission include improved diagnostic tests (chest X-ray, microbiological tests and blood tests) and respiratory support • the risks and disadvantages of hospital admission include spreading or catching COVID-19 and loss of contact with families. Managing breathlessness Managing breathlessness 4.4 Be aware that severe breathlessness often causes anxiety, which can then increase breathlessness further. See the NICE COVID-19 rapid guideline on managing symptoms (including at the end of life

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

313. COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community

-and- conditions#notice-of-rights). Page 2 of 19Contents Contents Overview 4 1 Communicating with patients and minimising risk 5 2 Treatment and care planning 6 3 General advice for managing COVID-19 symptoms 7 4 Managing cough 8 5 Managing fever 10 6 Managing breathlessness 11 7 Managing anxiety, delirium and agitation 15 8 Managing medicines for patients with COVID-19 17 9 Prescribing anticipatory medicines for patients with COVID-19 18 10 Healthcare workers 19 COVID-19 rapid guideline: managing symptoms (...) ) in the community (NG163) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 191 1 Communicating with patients and minimising Communicating with patients and minimising risk risk 1.1 For patients with COVID-19 symptoms explain: • that the key symptoms are cough, fever, breathlessness, anxiety, delirium and agitation but they may also have fatigue, muscle aches and headache • that they and people caring for them should follow

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

314. COVID-19 rapid guideline: haematopoietic stem cell transplantation

(NG164) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 5 of 181 1 Communicating with patients and minimising Communicating with patients and minimising risk risk 1.1 Communicate with patients, their families and carers and support their mental wellbeing, signposting to charities and support groups (including NHS volunteers) where available, to help alleviate any anxiety and fear they may have about COVID-19. 1.2

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

315. KardiaMobile for the ambulatory detection of atrial fibrillation

, and AF diagnosis- related anxiety reduced in 59.6%. Of those responding, 63.8% preferred continued use of KardiaMobile for AF detection. Strengths and limitations Strengths and limitations Authors acknowledge that quality of KardiaMobile ECG recordings may vary in an ambulatory setting, and that algorithm performance may vary in those with lower AF burden. Generalisability may be limited by small sample size and narrow inclusion criteria. Williams et al. (2015) Williams et al. (2015) Study size

2020 National Institute for Health and Clinical Excellence - Advice

316. Dexcom G6 for real-time continuous glucose monitoring

-prick monitoring. Diabetes UK noted the potential benefits of Dexcom on family life because of reducing the diabetes-related anxieties that parents and carers may experience when away from their children. However, the charity also noted that some people using CGM may experience burnout because of alarms or the volume of data CGM can produce. Data from the Dexcom G6 could be used to offer more tailored, person-centred advice and support around steps to improve diabetes self- management. Training

2020 National Institute for Health and Clinical Excellence - Advice

317. Space from Depression for treating adults with depression

, to measure severity of anxiety symptoms. T o compare, the national average starting and finishing PHQ-9 values are shown for people having guided self-help (using books) in IAPT services, and for people having any treatment in IAPT services. Across the 3 services, the change in PHQ-9 values was -3.7 for people who had Space for Depression, compared with -6.6 for people who had standard care. For comparison, the national change in PHQ-9 values for people having guided self-help (using books) was -5.0

2020 National Institute for Health and Clinical Excellence - Advice

318. EarlyCDT-Lung for cancer risk classification of indeterminate pulmonary nodules

such as pneumothorax and bleeding. Two specialists felt that patient exposure to CT scans would be reduced, as well as lessening anxieties over false positive results. Another noted that the early detection of malignant tumour is a potential benefit to the patient. One specialist noted that people with IPN who have comorbidities will benefit from EarlyCDT-Lung. Another felt people in socioeconomically deprived areas will benefit. One specialist noted that it would be interesting to know what effect early detection

2020 National Institute for Health and Clinical Excellence - Advice

319. Volanesorsen for treating familial chylomicronaemia syndrome

of their lives. One patient expert explained that the EQ-5D does not measure the aspects of quality of life that FCS affects, for example, strict adherence to a low- fat diet and the effect of that on their family and social lives. The committee noted that the EQ-5D does not contain questions about difficulties posed by the restricted diet, but does measure usual activities, pain and anxiety. Another patient expert noted that people with FCS may have adapted because living with the condition is their normal

2020 National Institute for Health and Clinical Excellence - Highly specialised technology

320. Testing strategies for Lynch syndrome in people with endometrial cancer

and their families results for both themselves and their families 4.2 There can be considerable anxiety and uncertainty associated with genetic testing for hereditary cancer syndromes such as Lynch syndrome. A patient expert explained that waiting for test results can be a very anxious time. T est results can have a substantial effect on a person, so it is very important that people understand the full implications of a diagnosis of Lynch syndrome, for themselves and their families. This is especially important (...) for people with a T esting strategies for Lynch syndrome in people with endometrial cancer (DG42) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 18 of 32learning disability, who may need support from a carer to fully engage in discussions about testing and to give informed consent. For people who have not had children yet, or who want more children, there may be anxiety and uncertainty about risk-reducing surgery

2020 National Institute for Health and Clinical Excellence - Diagnostics Guidance